Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANACEA trial of peri-PCI adenosine in anterior STEMI
ChiCTR2300073646Phase 4Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Mar 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of adenosine in acute ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Myocardial infarct size measured by cardiac magnetic resonance at 7 days after PCI. Started Mar 2023; status: recruiting.
02
Drugs
adenosine
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on ChiCTR2300073646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073646.